6AQQ.DE vs. NOV.DE

Last updated Jun 13, 2026

6AQQ.DE (Amundi Nasdaq 100 UCITS ETF EUR) is Nasdaq-100 fund tracking the Nasdaq 100®, while NOV.DE (Novo Nordisk A/S) is a stock. Over the past 10 years, 6AQQ.DE returned 21.35%/yr vs 17.16%/yr for NOV.DE. At a 0.25 correlation, their price movements are largely independent.

Performance

6AQQ.DE vs. NOV.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Amundi Nasdaq 100 UCITS ETF EUR (6AQQ.DE) and Novo Nordisk A/S (NOV.DE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, 6AQQ.DE achieves a 18.30% return, which is significantly higher than NOV.DE's -10.35% return. Over the past 10 years, 6AQQ.DE has outperformed NOV.DE with an annualized return of 21.35%, while NOV.DE has yielded a comparatively lower 17.16% annualized return.

6AQQ.DE

• 1D: 2.51%
• 1M: 1.82%
• YTD: 18.30%
• 6M: 19.72%
• 1Y: 36.66%
• 3Y*: 23.51%
• 5Y*: 17.90%
• 10Y*: 21.35%

NOV.DE

• 1D: 0.21%
• 1M: -0.63%
• YTD: -10.35%
• 6M: -8.05%
• 1Y: -42.30%
• 3Y*: 4.29%
• 5Y*: 20.26%
• 10Y*: 17.16%

*Multi-year figures are annualized to reflect compound growth (CAGR)

6AQQ.DE vs. NOV.DE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
6AQQ.DE Amundi Nasdaq 100 UCITS ETF EUR	18.30%	7.08%	33.77%	51.54%	-29.96%	39.62%	34.72%	42.90%	3.23%	15.90%
NOV.DE Novo Nordisk A/S	-10.35%	-45.88%	-9.45%	201.62%	32.53%	76.94%	16.00%	38.98%	-7.34%	39.52%

Correlation

The correlation between 6AQQ.DE and NOV.DE is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.15
Correlation (3Y) Calculated over the trailing 3-year period	0.15
Correlation (5Y) Calculated over the trailing 5-year period	0.18
Correlation (10Y) Calculated over the trailing 10-year period	0.23
Correlation (All Time) Calculated using the full available price history since Sep 21, 2010	0.25

The correlation between 6AQQ.DE and NOV.DE shifts across timeframes, from 0.15 (1 year) to 0.25 (all time), reflecting how their relationship changes across market environments.

Return for Risk

6AQQ.DE vs. NOV.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

6AQQ.DE

6AQQ.DE Risk / Return Rank: 75
6AQQ.DE Sharpe Ratio Rank: 80
6AQQ.DE Sortino Ratio Rank: 77
6AQQ.DE Omega Ratio Rank: 76
6AQQ.DE Calmar Ratio Rank: 78
6AQQ.DE Martin Ratio Rank: 66

NOV.DE

NOV.DE Risk / Return Rank: 12
NOV.DE Sharpe Ratio Rank: 9
NOV.DE Sortino Ratio Rank: 11
NOV.DE Omega Ratio Rank: 10
NOV.DE Calmar Ratio Rank: 12
NOV.DE Martin Ratio Rank: 17

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

6AQQ.DE vs. NOV.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amundi Nasdaq 100 UCITS ETF EUR (6AQQ.DE) and Novo Nordisk A/S (NOV.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	6AQQ.DE	NOV.DE	Difference
Sharpe ratio: Return per unit of total volatility	2.22	-0.85	+3.08
Sortino ratio: Return per unit of downside risk	2.97	-1.07	+4.04
Omega ratio: Gain probability vs. loss probability	1.39	0.85	+0.54
Calmar ratio: Return relative to maximum drawdown	3.58	-0.80	+4.37
Martin ratio: Return relative to average drawdown	10.43	-1.16	+11.59

6AQQ.DE vs. NOV.DE - Sharpe Ratio Comparison

The current 6AQQ.DE Sharpe Ratio is 2.22, which is higher than the NOV.DE Sharpe Ratio of -0.85. The chart below compares the historical Sharpe Ratios of 6AQQ.DE and NOV.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

6AQQ.DE vs. NOV.DE - Drawdown Comparison

The maximum 6AQQ.DE drawdown since its inception was -31.19%, smaller than the maximum NOV.DE drawdown of -76.24%. Use the drawdown chart below to compare losses from any high point for 6AQQ.DE and NOV.DE.

Drawdown Indicators

	6AQQ.DE	NOV.DE	Difference
Max Drawdown Largest peak-to-trough decline	-31.19%	-76.24%	+45.05%
Max Drawdown (1Y) Largest decline over 1 year	-10.01%	-53.78%	+43.77%
Max Drawdown (3Y) Largest decline over 3 years	-26.73%	-76.24%	+49.51%
Max Drawdown (5Y) Largest decline over 5 years	-31.19%	-76.24%	+45.05%
Max Drawdown (10Y) Largest decline over 10 years	-31.19%	-76.24%	+45.05%
Current Drawdown Current decline from peak	-2.78%	-70.33%	+67.55%
Average Drawdown Average peak-to-trough decline	-5.36%	-11.57%	+6.21%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.44%	35.53%	-32.09%

Volatility

6AQQ.DE vs. NOV.DE - Volatility Comparison

The current volatility for Amundi Nasdaq 100 UCITS ETF EUR (6AQQ.DE) is 5.37%, while Novo Nordisk A/S (NOV.DE) has a volatility of 9.39%. This indicates that 6AQQ.DE experiences smaller price fluctuations and is considered to be less risky than NOV.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	6AQQ.DE	NOV.DE	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.37%	9.39%	-4.02%
Volatility (6M) Calculated over the trailing 6-month period	11.60%	37.99%	-26.39%
Volatility (1Y) Calculated over the trailing 1-year period	16.15%	50.46%	-34.31%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.90%	57.30%	-37.40%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.67%	44.50%	-24.83%

Dividends

6AQQ.DE vs. NOV.DE - Dividend Comparison

6AQQ.DE has not paid dividends to shareholders, while NOV.DE's dividend yield for the trailing twelve months is around 4.10%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
6AQQ.DE Amundi Nasdaq 100 UCITS ETF EUR	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOV.DE Novo Nordisk A/S	4.10%	3.54%	1.59%	1.02%	2.36%	2.54%	3.97%	4.18%	5.34%	4.55%	7.38%	2.50%

Frequently Asked Questions

Can I hold both 6AQQ.DE and NOV.DE in my portfolio?

6AQQ.DE and NOV.DE have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.